ALLMedicine™ Poliomyelitis Center

May 16th, 2022 - COVID-19 has led to disruption in routine immunization programs around the world. Effective strategies need to be developed to address the decline in vaccine coverage to avoid preventable disease outbreaks. Our study reports a 4-days campaign for ...

May 9th, 2022 - Study duration per participant will be approximately 30 days including: 1 day of screening and vaccination, a phone call and a safety follow-up/end of study visit, at Day 8 and Day 30 after vaccine administration, respectively.

Apr 23rd, 2022 - Following implantation of patient-derived xenograft (PDX) breast carcinomas from three separate individuals, 33/51 female NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ (NSG) mice presented with progressive, unilateral to bilateral, ascending hindlimb paresis t...

Apr 21st, 2022 - Migration-flows pose the risk of poliovirus reintroduction from endemic countries to Greece. This study aims to evaluate serologic-immunity/vaccination against poliomyelitis in newly-arriving migrant children. Demographic-immunisation data and blo...

Apr 19th, 2022 - The unprovoked aggression of Russian military forces on Ukraine in February 2022 has caused a high influx of refugees, including children, to neighboring countries, particularly Poland. This caused additional pressures on the healthcare system and...

May 9th, 2022 - Study duration per participant will be approximately 30 days including: 1 day of screening and vaccination, a phone call and a safety follow-up/end of study visit, at Day 8 and Day 30 after vaccine administration, respectively.

Mar 31st, 2022 - This study will evaluate the immunogenicity and safety of concomitant administration of RotaTeq® (V260) and inactivated poliomyelitis vaccine (IPV) in Chinese infants. Its primary objective is to demonstrate that the immunogenicity of IPV in the c...

Feb 8th, 2022 - This multicenter trial is the first-in-human assessment of two novel oral polio vaccines for poliovirus type 1 and type 3. It will be an 8-arm, randomized, observer-blind, controlled trial, with Sabin monovalent vaccines serving as the control for...

Feb 2nd, 2022 - This study is an open clinical trial in children aged 6-71 months old. The purpose of this study is to evaluate the safety of EV71 vaccine (Vero cell), inactivated co-administration with other vaccines.The EV71 vaccine was manufactured by Sinovac ...

Feb 4th, 2021 - Two nOPV2 vaccine candidates have been developed as attenuated serotype 2 polioviruses derived from a modified Sabin 2 infectious complementary deoxyribonucleic acid (cDNA) clone. nOPV2 Candidate 1 (S2/cre5/S15domV/rec1/hifi3) and nOPV2 Candidate ...

Jul 15th, 2021 - I overheard a conversation between teachers regarding the COVID-19 vaccine as I was waiting in line to pick up my 3-year-old daughter from daycare. "I will get the vaccine but not my kids." "Absolutely. They're kids, not guinea pigs." "I have alre...

Mar 3rd, 2020 - Although wild poliovirus type 3 has not been detected globally for 7 years, the number of wild type 1 cases increased from 33 in 2018 to 173 in 2019. In response, a modified oral vaccine is being developed, according to Stephen Cochi, MD, of the C.

Nov 25th, 2019 - Kaposi sarcoma (KS) is a low-grade vascular tumor that is rare among the general US population, with an incidence rate of less than 1 per 100,000. 1 The tumor is more common among certain groups of individuals due to geographic differences in the p.

May 15th, 2019 - This transcript has been edited for clarity. Hello and welcome. I'm Dr George Lundberg and this is At Large at Medscape.* Many of you may know that I had the great privilege of being the editor-in-chief of JAMA (the Journal of the American Medical...

Sep 10th, 2018 - The US Food and Drug Administration (FDA) has approved a new formulation of Grifols' GamaSTAN immune globulin (human) for prophylaxis following exposure to hepatitis A virus (HAV) and for prevention or modification of measles in susceptible indivi...